- 4-Week Delivery: World’s fastest custom mouse model development.
- TurboMice™ Tech: Proprietary high-efficiency gene-editing platform.
- Full Capabilities: Expert conditional knockouts, knock-ins, and humanized models.
- Validated Quality: Guaranteed high precision and model viability.
Alb-IRES-iCre Mouse Model
| Strain Name | C57BL/6NMcl- Alb<sup>tm1(IRES-iCre)</sup>/MCL |
|---|---|
| Editing Type | Knock-In |
| Catalog No. | M02093 |
| Strain Background | C57BL/6NMcl |
| Gene Name | Albumin/Alb |
| Gene Name Synonyms | ALB,Albumin,Serum albumin,HSA,Alb-1 |
| NCBI No. | 11657 / MGI: 87991 |
| Preserving Method | Live or Cryopreserved |

- Hepatocyte-Specific Gene Knockout or Activation
- Liver Development and Hepatocyte Function Research
- Research on Fatty Liver, Liver Fibrosis, and Cirrhosis
- Investigation into Mechanisms of Hepatocellular Carcinoma Initiation and Progression
- Studies on Hepatic Lipid and Glucose Metabolism as Well as Drug Metabolism
- Research on Liver Injury, Regeneration, and Inflammatory Responses
- Shimshek DR, et al. Codon-improved Cre recombinase (iCre) expression in the mouse. Genesis. 2002;32:19–26.
- Kim DG, et al. Construction of a bifunctional mRNA in the mouse by using the internal ribosome entry site of the encephalomyocarditis virus. Mol Cell Biol. 1992;12:3636–3643.
- Postic C, et al. Dual roles for glucokinase in glucose homeostasis as determined by liver- and pancreatic $\beta$-cell-specific gene knock-outs using Cre recombinase. J Biol Chem. 1999;274:305–315.
- Schuler M, et al. Efficient temporally controlled targeted somatic mutagenesis in hepatocytes of the mouse. Genesis. 2004;39:167–172.
- Weisend CM, et al. Cre activity in fetal albCre mouse hepatocytes: utility for developmental studies. Genesis. 2009;47:789–792.
- Hepatocyte Specificity: Driven by the endogenous Alb promoter, iCre expression achieves specific Cre-loxP recombination within hepatocytes.
- Endogenous Expression Synchronization: Utilizing an IRES element allows independent translation of Alb and iCre, ensuring that iCre expression closely matches the tissue expression pattern of endogenous Alb.
- Constitutive and High-Efficiency Recombination: Operating without the need for tamoxifen induction, it continuously mediates the recombination of flox sites in hepatocytes, making it suitable for stable liver-specific gene knockout or activation.
- Preservation of Alb Function: The insertion of IRES-iCre typically does not disrupt the Alb coding sequence, thereby maintaining the function of endogenous albumin as much as possible while expressing iCre.

FAQ
Game-changing benefits?
While competitors highlight germline efficiency gains, shorter timelines and enhanced 3Rs animal welfare benefits for their technologies, these are merely incremental improvements over traditional approaches. In sharp contrast, our proprietary technology delivers fully pure, homogeneous lineages—every single cell of the mice is derived exclusively from totipotent ES cells, with guaranteed 100% germline transmission efficiency. To experience these unparalleled benefits firsthand, enquire about your custom mouse model project with us or order embryos for in-house validation at your facility.
How much for a project assessment?
•Free initial design proposal with zero obligations.
•Request a free quote!
Who owns the mouse lP? Do l need a licence from Mingceler?
All model generation projects of Mingceler operate under a fee-for-service framework.
IP Ownership: All intellectual property rights related to custom mouse models, including derived organs, tissues, cells, and biological materials, are the sole and exclusive property of the Client.
Third-Party Transfer Permission: The Client may independently decide to retain, utilize, or commercialize their custom models project materials (e.g., targeting vectors, ES cells, mouse lines) without the need for prior consent from Mingceler.
Licensing Exemption: The Client has full autonomy over all uses of the custom models or their derivatives, including but not limited to commercialization, distribution to third parties, and publication involving model data. No written license from Mingceler is required for such uses.
